Within Pall Biotech, Nathan is responsible for overseeing the US bioreactor applications team, whose role it is to partner with cutomers to help them achieve the best possible results with Pall bioreactors through activities including training, application support, consultancy, and troubleshooting. Customer bioreactor support spans a wide range of activities including pre-sale inquiries, bioreactor adoption, process development, and clinical manufacturing. Prior to managing the US bioreactor applications team, Nathan was a member of the applications team. Prior to joining Pall, Nathan was an upstream process development scientist at Noveome Biotherapeutics while using Pall bioreactors. Nathan also held cGMP manufacturing positions at Noveome Biotherapeutics and GlaxoSmithKline.